IL13 and infectious mononucleosis: This indicates that patients with stomach pain, bloating, and symptoms of an irritable bowel at baseline, severe gastrointestinal symptoms when they contracted mononucleosis, and low levels of IL-13 and/or IL-5 at baseline had nearly an 80% chance of developing severe ME/CFS six months following IM.